Zentek Ltd. (ZTEK)
USD 0.98
(-4.85%)
USD 0.98
(-4.85%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -11.7 Million CAD | 18.8% |
| 2022 | -14.41 Million CAD | 62.75% |
| 2021 | -38.69 Million CAD | -900.2% |
| 2020 | -3.86 Million CAD | -152.14% |
| 2019 | -1.53 Million CAD | 36.81% |
| 2018 | -2.42 Million CAD | -55.2% |
| 2017 | -1.56 Million CAD | 44.92% |
| 2016 | -2.84 Million CAD | 32.33% |
| 2015 | -4.19 Million CAD | -39.2% |
| 2014 | -3.01 Million CAD | 14.44% |
| 2013 | -3.52 Million CAD | -49.87% |
| 2012 | -2.35 Million CAD | -126.3% |
| 2011 | -1.03 Million CAD | 16.32% |
| 2010 | -1.24 Million CAD | -739.48% |
| 2009 | -147.95 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.55 Million CAD | -3.89% |
| 2023 Q1 | -5.01 Million CAD | -83.63% |
| 2023 FY | -11.7 Million CAD | 18.8% |
| 2023 Q4 | -2.45 Million CAD | 8.47% |
| 2023 Q3 | -2.68 Million CAD | 21.15% |
| 2023 Q2 | -3.4 Million CAD | 32.1% |
| 2022 Q3 | -3.23 Million CAD | 5.02% |
| 2022 Q4 | -2.73 Million CAD | 15.68% |
| 2022 FY | -14.41 Million CAD | 62.75% |
| 2022 Q1 | -5.03 Million CAD | 84.07% |
| 2022 Q2 | -3.41 Million CAD | 32.26% |
| 2021 Q3 | -1.91 Million CAD | 35.03% |
| 2021 Q4 | -31.6 Million CAD | -1550.35% |
| 2021 Q2 | -2.94 Million CAD | -58.52% |
| 2021 Q1 | -1.85 Million CAD | -51.3% |
| 2021 FY | -38.69 Million CAD | -900.2% |
| 2020 Q1 | -356.32 Thousand CAD | 43.99% |
| 2020 FY | -3.86 Million CAD | -152.14% |
| 2020 Q2 | -434.82 Thousand CAD | -22.03% |
| 2020 Q3 | -1.84 Million CAD | -325.09% |
| 2020 Q4 | -1.22 Million CAD | 33.51% |
| 2019 Q4 | -636.14 Thousand CAD | -303.97% |
| 2019 Q3 | -157.47 Thousand CAD | 57.19% |
| 2019 Q1 | -379.4 Thousand CAD | 37.42% |
| 2019 Q2 | -367.85 Thousand CAD | 3.04% |
| 2019 FY | -1.53 Million CAD | 36.81% |
| 2018 Q2 | -1 Million CAD | -295.36% |
| 2018 Q3 | -558.82 Thousand CAD | 44.56% |
| 2018 Q4 | -606.3 Thousand CAD | -8.5% |
| 2018 FY | -2.42 Million CAD | -55.2% |
| 2018 Q1 | -254.97 Thousand CAD | 39.08% |
| 2017 Q3 | -314.14 Thousand CAD | -8.06% |
| 2017 FY | -1.56 Million CAD | 44.92% |
| 2017 Q4 | -418.56 Thousand CAD | -33.24% |
| 2017 Q2 | -290.7 Thousand CAD | 46.28% |
| 2017 Q1 | -541.1 Thousand CAD | 16.39% |
| 2016 Q2 | -1.02 Million CAD | -158.95% |
| 2016 Q3 | -774.77 Thousand CAD | 24.3% |
| 2016 Q1 | -395.22 Thousand CAD | 44.65% |
| 2016 Q4 | -647.16 Thousand CAD | 16.47% |
| 2016 FY | -2.84 Million CAD | 32.33% |
| 2015 Q3 | -833.44 Thousand CAD | 37.75% |
| 2015 Q4 | -714.01 Thousand CAD | 14.33% |
| 2015 Q1 | -1.31 Million CAD | -119.92% |
| 2015 Q2 | -1.33 Million CAD | -2.08% |
| 2015 FY | -4.19 Million CAD | -39.2% |
| 2014 Q2 | -1.03 Million CAD | -61.27% |
| 2014 FY | -3.01 Million CAD | 14.44% |
| 2014 Q3 | -743.39 Thousand CAD | 28.14% |
| 2014 Q4 | -596.34 Thousand CAD | 19.78% |
| 2014 Q1 | -641.46 Thousand CAD | 9.58% |
| 2013 FY | -3.52 Million CAD | -49.87% |
| 2013 Q1 | -840.84 Thousand CAD | 24.98% |
| 2013 Q2 | -885.92 Thousand CAD | -5.36% |
| 2013 Q3 | -1.08 Million CAD | -22.88% |
| 2013 Q4 | -709.39 Thousand CAD | 34.84% |
| 2012 Q1 | -384.69 Thousand CAD | -58.61% |
| 2012 Q2 | -292.31 Thousand CAD | 24.01% |
| 2012 Q3 | -554.1 Thousand CAD | -89.56% |
| 2012 Q4 | -1.12 Million CAD | -102.28% |
| 2012 FY | -2.35 Million CAD | -126.3% |
| 2011 Q1 | -77.64 Thousand CAD | 79.15% |
| 2011 Q2 | -411.86 Thousand CAD | -430.44% |
| 2011 Q3 | -307.24 Thousand CAD | 25.4% |
| 2011 Q4 | -242.54 Thousand CAD | 21.06% |
| 2011 FY | -1.03 Million CAD | 16.32% |
| 2010 FY | -1.24 Million CAD | -739.48% |
| 2010 Q3 | -502.82 Thousand CAD | -98.59% |
| 2010 Q1 | -113.63 Thousand CAD | 23.19% |
| 2010 Q2 | -253.19 Thousand CAD | -122.82% |
| 2010 Q4 | -372.36 Thousand CAD | 25.95% |
| 2009 Q4 | -147.95 Thousand CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 FY | -147.95 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 81.517% |
| AngioDynamics, Inc. | -184.34 Million USD | 93.651% |
| AtriCure, Inc. | -30.43 Million USD | 61.548% |
| Avinger, Inc. | -18.32 Million USD | 36.114% |
| Azenta, Inc. | -14.25 Million USD | 17.907% |
| BioLife Solutions, Inc. | -66.42 Million USD | 82.381% |
| The Cooper Companies, Inc. | 294.2 Million USD | 103.978% |
| Daxor Corporation | 280.64 Thousand USD | 4270.464% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 22.99% |
| Femasys Inc. | -14.24 Million USD | 17.85% |
| GlucoTrack, Inc. | -7.09 Million USD | -64.915% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -242.723% |
| Hologic, Inc. | 789.5 Million USD | 101.482% |
| ICU Medical, Inc. | -29.65 Million USD | 60.533% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 100.651% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 14.825% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 138.877% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -75.645% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -75.645% |
| Masimo Corporation | 81.5 Million USD | 114.361% |
| Microbot Medical Inc. | -10.74 Million USD | -8.976% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 200.676% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 112.397% |
| Nephros, Inc. | -1.57 Million USD | -643.11% |
| NovoCure Limited | -207.04 Million USD | 94.347% |
| NEXGEL, Inc. | -3.15 Million USD | -270.731% |
| NEXGEL, Inc. | -3.15 Million USD | -270.731% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 87.657% |
| OraSure Technologies, Inc. | 53.65 Million USD | 121.813% |
| Pro-Dex, Inc. | 2.12 Million USD | 650.258% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 72.272% |
| Predictive Oncology Inc. | -13.98 Million USD | 16.304% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -296.56% |
| QuidelOrtho Corporation | -10.1 Million USD | -15.881% |
| Repligen Corporation | 41.57 Million USD | 128.15% |
| Sanara MedTech Inc. | -4.3 Million USD | -171.984% |
| STAAR Surgical Company | 21.34 Million USD | 154.827% |
| Sharps Technology, Inc. | -9.84 Million USD | -18.923% |
| Utah Medical Products, Inc. | 16.63 Million USD | 170.358% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 91.133% |
| Jin Medical International Ltd. | 2.87 Million USD | 506.638% |